Investigation of Foscan® interactions with plasma proteins

Biochimica et Biophysica Acta - General Subjects

Volumn 1725, Issue 3, 2005, Pages 394-402

  Sasnouski, Siarhei ^a,b   Zorin, Vladimir ^b   Khludeyev, Ivan ^b   D'Hallewin, Marie Ange ^a   Guillemin, François ^a   Bezdetnaya, Lina ^a  

^a CENTRE DE RECHERCHE EN AUTOMATIQUE DE NANCY   (France)

^b BELARUSIAN STATE UNIVERSITY   (Belarus)

Author keywords

Bovine serum albumin (BSA); Disaggregation; Foscan ; Gel filtration chromatography; Lipoprotein; Photodynamic therapy (PDT)

Indexed keywords

ALBUMIN; BOVINE SERUM ALBUMIN; DIMER; LIPOPROTEIN; PHOTOSENSITIZING AGENT; PLASMA PROTEIN; TEMOPORFIN; MESOPORPHYRIN; SERUM ALBUMIN;

ARTICLE; CONCENTRATION (PARAMETERS); GEL FILTRATION CHROMATOGRAPHY; INCUBATION TEMPERATURE; KINETICS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN INTERACTION; SPECTROSCOPY; ANIMAL; BLOOD; CATTLE; CHEMISTRY; GEL CHROMATOGRAPHY; LIGHT; METABOLISM; RADIATION SCATTERING; SOLUTION AND SOLUBILITY;

BOVINAE;

ANIMALS; CATTLE; CHROMATOGRAPHY, GEL; KINETICS; LIGHT; LIPOPROTEINS; MESOPORPHYRINS; PHOTOSENSITIZING AGENTS; SCATTERING, RADIATION; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; SOLUTIONS; SPECTRUM ANALYSIS;

EID: 25844507869     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2005.06.014     Document Type: Article

References (34)

1. B.W. Henderson, and T.J. Dougherty How does photodynamic therapy work? Photochem. Photobiol. 55 1992 145 157
2. R.W. Redmond, E.J. Land, and T.G. Truscott Aggregation effects on the photophysical properties of porphyrins in relation to mechanisms involved in photodynamic therapy Adv. Exp. Med. Biol. 193 1985 293A 302A
3. C. Tanielian, C. Schweitzer, R. Mechin, and C. Wolff Quantum yield of singlet oxygen production by monomeric and aggregated forms of hematoporphyrin derivative Free Radical Biol. Med. 30 2001 208 212
4. L. Ma, J. Moan, and K. Berg Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers Int. J. Cancer 57 1994 883 888
5. D.J. Ball, S.R. Wood, D.I. Vernon, J. Griffiths, T.M. Dubbelman, and S.B. Brown The characterisation of three substituted zinc phthalocyanines of differing charge for use in photodynamic therapy. A comparative study of their aggregation and photosensitising ability in relation to mTHPC and polyhaematoporphyrin J. Photochem. Photobiol., B Biol. 45 1998 28 35
6. R.K. Chowdhary, I. Sharif, N. Chansarkar, D. Dolphin, L. Ratkay, S. Delaney, and H. Meadows Correlation of photosensitizer delivery to lipoproteins and efficacy in tumor and arthritis mouse models; comparison of lipid-based and Pluronic P123 formulations J. Pharm. Pharm. Sci. 6 2003 198 204
7. G. Jori, and E. Reddi The role of lipoproteins in the delivery of tumour-targeting photosensitizers Int. J. Biochem. 25 1993 1369 1375
8. T. Peters All About Albumin 1995 Academic Press San Diego
9. D. Kessel, P. Thompson, K. Saatio, and K.D. Nantwi Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine Photochem. Photobiol. 45 1987 787 790
10. M. Korbelik, and J. Hung Cellular delivery and retention of Photofrin II: the effects of interaction with human plasma proteins Photochem. Photobiol. 53 1991 501 510
11. M. Kongshaug Distribution of tetrapyrrole photosensitizers among human plasma proteins Int. J. Biochem. 24 1992 1239 1265
12. M.O. Obochi, R.W. Boyle, and J.E. van Lier Biological activities of phthalocyanines. XIII. The effects of human serum components on the in vitro uptake and photodynamic activity of zinc phthalocyanine Photochem. Photobiol. 57 1993 634 640
13. T. Tsuchida, G. Zheng, R.K. Pandey, W.R. Potter, D.A. Bellnier, B.W. Henderson, H. Kato, and T.J. Dougherty Correlation between site II-specific human serum albumin (HSA) binding affinity and murine in vivo photosensitizing efficacy of some Photofrin components Photochem. Photobiol. 66 1997 224 228
14. R. Bonnett, R.D. White, U.J. Winfield, and M.C. Berenbaum Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers Biochem. J. 261 1989 277 280
15. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng Photodynamic therapy J. Natl. Cancer Inst. 90 1998 889 905
16. M.P. Copper, I.B. Tan, H. Oppelaar, M.C. Ruevekamp, and F.A. Stewart Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck Arch. Otolaryngol., Head. Neck. Surg. 129 2003 709 711
17. C. Hopper, A. Kubler, H. Lewis, I.B. Tan, and G. Putnam mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma Int. J. Cancer 111 2004 138 146
18. H.J. Hopkinson, D.I. Vernon, and S.B. Brown Identification and partial characterization of an unusual distribution of the photosensitizer meta-tetrahydroxyphenyl chlorin (temoporfin) in human plasma Photochem. Photobiol. 69 1999 482 488
19. D. Kessel Transport and localisation of m-THPC in vitro Int. J. Clin. Pract. 53 1999 263 267
20. A.T. Michael-Titus, R. Whelpton, and Z. Yaqub Binding of temoporfin to the lipoprotein fractions of human serum Br. J. Clin. Pharmacol. 40 1995 594 597
21. D. Kessel, and E. Sykes Transport, localization, and phototoxicity of m-THPC Proc. SPIE 3592 1999 37 42
22. I. Belitchenko, V. Melnikova, L. Bezdetnaya, H. Rezzoug, J.L. Merlin, A. Potapenko, and F. Guillemin Characterization of photodegradation of meta-tetra(hydroxyphenyl)chlorin (mTHPC) in solution: biological consequences in human tumor cells Photochem. Photobiol. 67 1998 584 590
23. R.F. Pasternack, and P.J. Collings Resonance light scattering: a new technique for studying chromophore aggregation Science 269 1995 935 939
24. P.J. Collings, E.J. Gibbs, T.E. Starr, O. Vafek, C. Yee, L.A. Pomerance, and R.F. Pasternack Resonance light scattering and its application in determining the size, shape, and aggregation number for supramolecular assemblies of chromophores J. Phys. Chem., B 103 1999 8474 8481
25. R. Bonnett, B.D. Djelal, and N. Angelina Physical and chemical studies related to the development of m-THPC (FOSCAN®) for the photodynamic therapy (PDT) of tumours J. Porphyrins Phthalocyanines 5 2001 652 661
26. R. Bonnett, P. Charlesworth, B.D. Djelal, S. Foley, D.J. McGarvey, and T.G. Truscott Photophysical properties of 5,10,15,20-tetrakis(m-hydroxyphenyl) porphyrin (m-THPP), 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin (m-THPC) and 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (m-THPBC): a comparative study J. Chem. Soc., Perkin Trans. 22 1999 325 328
27. D.M. Fiedler, F. Wierrani, G. Schnitzhofer, J.C. Stewart, K. Gharehbaghi, W. Grunberger, and B. Krammer Does the in-vitro efficiency of meso-tetrahydroxy-phenyl-chlorin depend on pre-treatment of sensitizer? J. Photochem. Photobiol., B Biol. 38 1997 241 244
28. B.M. Aveline, T. Hasan, and R.W. Redmond The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA) J. Photochem. Photobiol., B Biol. 30 1995 161 169
29. V. Rosenberger, and R. Margalit Thermodynamics of the binding of hematoporphyrin ester, a hematoporphyrin derivative-like photosensitizer, and its components to human serum albumin, human high-density lipoprotein and human low-density lipoprotein Photochem. Photobiol. 58 1993 627 630
30. K. Kuzelova, M. Mrhalova, and Z. Hrkal Kinetics of heme interaction with heme-binding proteins: the effect of heme aggregation state Biochim. Biophys. Acta 1336 1997 497 501
31. S. Bonneau, C. Vever-Bizet, P. Morliere, J.C. Maziere, and D. Brault Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins Biophys. J. 83 2002 3470 3481
32. M. Kongshaug, J. Moan, and S.B. Brown The distribution of porphyrins with different tumour localising ability among human plasma proteins Br. J. Cancer 59 1989 184 188
33. A.M. Ronn, J. Batti, C.J. Lee, D. Yoo, M.E. Siegel, M. Nouri, L.A. Lofgren, and B.M. Steinberg Comparative biodistribution of meta- Tetra(Hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy Lasers Surg. Med. 20 1997 437 442
34. T. Glanzmann, C. Hadjur, M. Zellweger, P. Grosiean, M. Forrer, J.P. Ballini, P. Monnier, H. van den Bergh, C.K. Lim, and G. Wagnieres Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy Photochem. Photobiol. 67 1998 596 602